NASDAQ:ABUS – Knox Daily

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Arbutus Biopharma

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Arbutus Biopharma

Insiders Updates

Arbutus Biopharma Corp’s recent filing unveils that its Director MANCHESTER KEITH S unloaded Company’s shares for reported $32637.0 on Aug

Stock Earnings

Arbutus Biopharma Corp’s filing revealed that its Director MANCHESTER KEITH S unloaded Company’s shares for reported $32637.0 on Aug 14

Stock Earnings

Arbutus Biopharma Corp’s recently made public that its Director MANCHESTER KEITH S unloaded Company’s shares for reported $32637.0 on Aug

Analysts Viewpoint

Arbutus Biopharma Corp’s recent filing unveils that its Director MANCHESTER KEITH S unloaded Company’s shares for reported $32637.0 on Aug

Insiders Updates

Arbutus Biopharma Corp’s recent filing unveils that its Director MANCHESTER KEITH S unloaded Company’s shares for reported $32637.0 on Aug

Analysts Viewpoint

Arbutus Biopharma Corp’s recent filing unveils that its Director MANCHESTER KEITH S unloaded Company’s shares for reported $32637.0 on Aug

Insiders Updates

In a filing, Arbutus Biopharma Corp revealed its Director MANCHESTER KEITH S unloaded Company’s shares for reported $32637.0 on Aug

Insiders Updates

In a filing, Arbutus Biopharma Corp revealed its Director MANCHESTER KEITH S unloaded Company’s shares for reported $32637.0 on Aug

Tag: NASDAQ:ABUS